Inflammatory myofibroblastic tumour of an unusual presentation in the uterine cervix: a case report.
Alfonso López de SaAlejandro PascualJavier Garcia SantosRamiro MendezMonica BellonMar RamirezFatima MatuteCristina Del ArcoAránzazu ManzanoPluvio CoronadoAntonio CasadoGloria MarquinaPublished in: World journal of surgical oncology (2021)
Inflammatory myofibroblastic tumour remains a rare entity yet to be fully elucidated. The diagnosis is based on pathological study due to the lack of typical clinical manifestations and typical radiological images. Surgical resection is the most frequent treatment, whereas chemotherapy and radiotherapy are restricted to locally advanced or metastatic disease. Tirosine kinase inhibitor crizotinib has shown promising results especially in tumours harbouring ALK mutation.
Keyphrases
- locally advanced
- squamous cell carcinoma
- rectal cancer
- neoadjuvant chemotherapy
- radiation therapy
- phase ii study
- oxidative stress
- advanced non small cell lung cancer
- small cell lung cancer
- deep learning
- convolutional neural network
- preterm birth
- combination therapy
- clinical trial
- replacement therapy
- open label
- epidermal growth factor receptor